PMID: 37931265
Ma T, Shen X, Shi X, Sakandar HA, Quan K, Li Y, et al
Safety Profile: With extensive clinical experience, dual agonists have a well-characterized safety profile, making them a reliable option for many patients
It is not yet approved for routine prescribing, and the final licensed dose, availability, long-term safety profile and prescribing guidance are not yet confirmed
As the New Year approaches, many consumers are comparing prescription-based weight management programs with lower-cost, non-prescription wellness products-especially products marketed online as "GLP-1 patches." If you have been seeing ads for these and are unsure what is real or just marketing, you are not alone
Understanding your bodys response and speaking to your healthcare provider about side effects is crucial for long-term success